diffusing capacity for carbon monoxide
Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis
7
CARBON MONOXIDE UPTAKE AND PULMONARY DIFFUSING CAPACITY IN NORMAL SUBJECTS AT REST AND DURING EXERCISE
11
PULMONARY DIFFUSING CAPACITY: A COMPARISON OF BREATH HOLDING AND STEADY STATE METHODS USING CARBON MONOXIDE
11
THE MEASUREMENT OF PULMONARY DIFFUSING CAPACITY FOR CARBON MONOXIDE BY A REBREATHING METHOD
15
Functional Significance of a Low Pulmonary Diffusing Capacity for Carbon Monoxide
13
A STUDY OF THE MECHANISM BY WHICH EXERCISE INCREASES THE PULMONARY DIFFUSING CAPACITY FOR CARBON MONOXIDE
18
Impact of diabetes mellitus on functional exercise capacity and pulmonary functions in patients with diabetes and healthy persons
8
Patterns of diffuse parenchymal lung disease manifestations in collagen vascular disease and in relation to DLCO
76
A Standardized Breath Holding Technique for the Clinical Measurement of the Diffusing Capacity of the Lung for Carbon Monoxide
18
Maximal Diffusing Capacity of the Lung for Carbon Monoxide
8
STUDIES OF RESPIRATORY PHYSIOLOGY IN CHILDREN
11
The changing landscape of pulmonary arterial hypertension and implications for patient care
8
Overlaps and uncertainties of smoking-related idiopathic interstitial pneumonias
9
Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations
5
Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study
10
Paradoxical worsening of hypoxemia in a patient treated by noninvasive positive pressure ventilation for obesity hypoventilation syndrome with concomitant obstructive sleep apnea: a case report
5
Epidemiology and disease characteristics of systemic sclerosis related pulmonary arterial hypertension: results from a real life screening programme
10
THE EFFECT OF CHANGES IN VENTILATION AND PULMONARY BLOOD FLOW ON THE DIFFUSING CAPACITY OF THE LUNG
17
Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
9
miR 155 in the progression of lung fibrosis in systemic sclerosis
13